AAAAAA

   
Results: 1-14 |
Results: 14
SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL-TRANSPLANT RECIPIENTS - A REPORT OF THE CANADIAN NEORAL RENAL STUDY-GROUP
Authors: COLE E KEOWN P LANDSBERG D HALLORAN P SHOKER A RUSH D JEFFREY J RUSSELL D STILLER C MUIRHEAD N PAUL L ZALTZMAN J LOERTSCHER R DALOZE P DANDAVINO R BOUCHER A HANDA P LAWEN J BELITSKY P PARFREY P TAN A HENDRICKS L
Citation: E. Cole et al., SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL-TRANSPLANT RECIPIENTS - A REPORT OF THE CANADIAN NEORAL RENAL STUDY-GROUP, Transplantation, 65(4), 1998, pp. 505-510
USE OF RABBIT ANTI-THYMOCYTE GLOBULIN FOR INDUCTION IMMUNOSUPPRESSIONIN HIGH-RISK KIDNEY-TRANSPLANT RECIPIENTS
Authors: BELITSKY P MACDONALD AS LAWEN J MCALISTER V BITTERSUERMANN H KIBERD B
Citation: P. Belitsky et al., USE OF RABBIT ANTI-THYMOCYTE GLOBULIN FOR INDUCTION IMMUNOSUPPRESSIONIN HIGH-RISK KIDNEY-TRANSPLANT RECIPIENTS, Transplantation proceedings, 29(7A), 1997, pp. 16-17
LONG-TERM FOLLOW-UP (5 AND 10 YEARS) IN RECIPIENTS OF HLA IDENTICAL LIVING-RELATED DONOR KIDNEY GRAFTS RECEIVING CONTINUOUS CYCLOSPORINE COMPARED WITH AZATHIOPRINE
Authors: MACDONALD AS BELITSKY P BITTERSUERMANN H LAWEN J MACSWEEN M KIBERD B WEST K MCALISTER VC
Citation: As. Macdonald et al., LONG-TERM FOLLOW-UP (5 AND 10 YEARS) IN RECIPIENTS OF HLA IDENTICAL LIVING-RELATED DONOR KIDNEY GRAFTS RECEIVING CONTINUOUS CYCLOSPORINE COMPARED WITH AZATHIOPRINE, Transplantation proceedings, 29(1-2), 1997, pp. 190-190
FINANCIAL IMPACT OF COLD ISCHEMIA TIME IN RENAL-TRANSPLANTATION
Authors: BARAMA A KIBERD BA BELITSKY P MACDONALD AS BITTERSUERMANN H WEST K LAWEN J MCALISTER VC
Citation: A. Barama et al., FINANCIAL IMPACT OF COLD ISCHEMIA TIME IN RENAL-TRANSPLANTATION, Transplantation proceedings, 29(1-2), 1997, pp. 1563-1564
A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS
Authors: KEOWN P LANDSBERG D HALLORAN P SHOKER A RUSH D JEFFERY J RUSSELL D STILLER C MUIRHEAD N COLE E PAUL L ZALTZMAN J LOERTSCHER R DALOZE P DANDAVINO R BOUCHER A HANDA P LAWEN J BELITSKY P PARFREY P
Citation: P. Keown et al., A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS, Transplantation, 62(12), 1996, pp. 1744-1752
A BLINDED, RANDOMIZED CLINICAL-TRIAL OF MYCOPHENOLATE MOFETIL FOR THEPREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL-TRANSPLANTATION
Authors: KEOWN P HAYRY P MATHEW T MORRIS P STILLER C BARKER C CARR L LANDSBERG D HARDIE I RIGBY R ISONIEMI H GRAY D BELITSKY P MCDONALD A CLARKSON A BARRATT L BUCHHOLZ B WALKER R KIRSTE G MUIRHEAD N TILLER D DUGGIN G HALLORAN P DALOZE P RUSSELL D LUDWIN D VIALTEL P BINSWANGER U BUCKELS JAC TOURAINE JL HICKEY D REMUZZI G LOCATELLI B LAM FT
Citation: P. Keown et al., A BLINDED, RANDOMIZED CLINICAL-TRIAL OF MYCOPHENOLATE MOFETIL FOR THEPREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL-TRANSPLANTATION, Transplantation, 61(7), 1996, pp. 1029-1037
THE FATE OF THE FAILED RENAL-TRANSPLANT
Authors: KIBERD BA BELITSKY P
Citation: Ba. Kiberd et P. Belitsky, THE FATE OF THE FAILED RENAL-TRANSPLANT, Transplantation, 59(4), 1995, pp. 645-647
EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CYCLOSPORINE CLEARANCE AND USE IN RENAL-TRANSPLANT PATIENTS
Authors: SKETRIS IS METHOT ME NICOL D BELITSKY P KNOX MG
Citation: Is. Sketris et al., EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CYCLOSPORINE CLEARANCE AND USE IN RENAL-TRANSPLANT PATIENTS, The Annals of pharmacotherapy, 28(11), 1994, pp. 1227-1231
RATIONAL CLINICAL REGIMENS FOR KIDNEY-TRANSPLANT IMMUNOSUPPRESSION
Authors: BELITSKY P
Citation: P. Belitsky, RATIONAL CLINICAL REGIMENS FOR KIDNEY-TRANSPLANT IMMUNOSUPPRESSION, Transplantation proceedings, 26(5), 1994, pp. 2485-2489
COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS
Authors: SKETRIS IS LAWEN JG BEAUREGARDZOLLINGER L BELITSKY P LANDSBERG D GIVNER ML KEOWN P
Citation: Is. Sketris et al., COMPARISON OF THE PHARMACOKINETICS OF CYCLOSPORINE SANDIMMUNE WITH SANDIMMUNE-NEORAL IN STABLE RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 26(5), 1994, pp. 2961-2963
FATE OF RENAL-ALLOGRAFTS TRANSPLANTED IN PATIENTS WITH URINARY-DIVERSION
Authors: HATCH DA BELITSKY P BARRY JM NOVICK AC TAYLOR RJ JORDAN ML SAGALOWSKY AI ZAONTZ MR
Citation: Da. Hatch et al., FATE OF RENAL-ALLOGRAFTS TRANSPLANTED IN PATIENTS WITH URINARY-DIVERSION, Transplantation, 56(4), 1993, pp. 838-842
REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL-TRANSPLANT RECIPIENTS
Authors: NICOL DL MACDONALD AS BELITSKY P LEE S COHEN AD BITTERSUERMANN H LOWEN J WHALEN A",BOLLINGER
Citation: Dl. Nicol et al., REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 55(4), 1993, pp. 841-846
PROGNOSTIC FACTORS IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS
Authors: HANSON PR BELITSKY P MILLARD OH LANNON SG
Citation: Pr. Hanson et al., PROGNOSTIC FACTORS IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, CAN J SURG, 36(6), 1993, pp. 537-540
LOW-DOSE SUBCUTANEOUS ERYTHROPOIETIN CORRECTS THE ANEMIA OF RENAL-TRANSPLANT FAILURE
Authors: JINDAL KK HIRSCH DJ BELITSKY P WHALEN MA
Citation: Kk. Jindal et al., LOW-DOSE SUBCUTANEOUS ERYTHROPOIETIN CORRECTS THE ANEMIA OF RENAL-TRANSPLANT FAILURE, Nephrology, dialysis, transplantation, 7(2), 1992, pp. 143-146
Risultati: 1-14 |